Atranorin inhibits NLRP3 inflammasome activation by targeting ASC and protects NLRP3 inflammasome-driven diseases

Haoyu Wang(Chinese Academy of Sciences), Wei Tang(Shanghai Institute of Materia Medica)
Acta Pharmacologica Sinica
March 24, 2023
Cited by 31


Related Papers